Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × Daunorubicin × Clear all

NCT03568994 2026-01-27

ATACC AML

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute